Products

📄 Extensive Product Profile: Understanding Anaday 1mg Tablet Anaday 1mg contains Anastrozole, an advanced, non-steroidal selective third-generation Aromatase Inhibitor (AI). Manufactured to the highest global pharmaceutical standards, it is heavily relied upon by oncologists and healthcare institutions worldwide to manage hormone receptor-positive malignancies in postmenopausal women. 1. Clinical Indications & Usage Adjuvant Treatment of Early Breast Cancer: Prescribed for postmenopausal women with hormone receptor-positive early-stage breast cancer. First-Line Advanced Breast Cancer Treatment: Indicated for postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer. Second-Line Advanced Breast Cancer Treatment: Deployed for the treatment of advanced breast cancer in postmenopausal women experiencing disease progression following tamoxifen therapy. 2. Mechanism of Action: How Anaday Works Aromatase Enzyme Inhibition: In postmenopausal women, the primary source of circulating estrogen is the conversion of adrenal androgens (androstenedione and testosterone) into estrone and estradiol by the aromatase enzyme complex in peripheral tissues. Anaday selectively blocks this system. Total Estrogen Suppression: By inhibiting peripheral aromatase, Anaday cuts off serum estradiol concentrations by more than 80%, starving estrogen-dependent breast cancer cells of the growth signals required for replication and survival. 3. Administration and Dosing Guide Administration Route: Oral tablet formulation. It must be swallowed whole with water and should never be crushed, chewed, split, or dissolved. Food Interactions: Tablets can be taken consistently either with or without food. Standard Schedule: The typical recommended adult dosage is 1 mg (one tablet) taken orally once daily, at the same time each day. For early breast cancer adjuvant therapy, treatment is clinically recommended to continue for up to 5 years. ⚠️ Safety, Side Effects, and Monitoring Bone Mineral Density (BMD) Depletion: Estrogen reduction increases bone resorption. Patients are at higher risk for bone loss, osteoporosis, and bone fractures. Baseline and routine DEXA scans are highly recommended. Ischemic Cardiovascular Events: Postmenopausal women with pre-existing ischemic heart disease may experience a higher incidence of cardiovascular events. Routine cardiac monitoring is advised. Common Side Effects: Hot flashes, joint pain, stiffness, or arthritis (arthralgia), systemic fatigue, nausea, headache, skin rash, and mild hair thinning. 📦 Storage and Handling Specifications (Anaday 1mg) Storage Framework: Store Anaday 1mg tablets below 30°C (86°F) in a dry, dark, climate-controlled, certified pharmaceutical warehouse corridor. Environmental Safeguards: Keep medications sealed inside their original manufacturer protective packaging. Protect completely from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) Verified Batch Origin Ledger & GMP Tracking Global Import/Export Customs Clearance and Compliance Documentation PRESCRIPTION MEDICINE IS: YES Clinical Disclaimer: This profile is compiled strictly for international wholesale procurement, commercial trade evaluation, and institutional research. Anaday 1mg is a specialized oncology medication available exclusively under valid clinical authorization (PRESCRIPTION MEDICINE IS YES). It must be handled, dispensed, and utilized solely under the direct guidance of registered specialists. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📄 Extensive Product Profile: Understanding Bdpoma 4mg Capsule Bdpoma 4mg Capsule contains Pomalidomide, an exceptionally potent, third-generation immunomodulatory antineoplastic agent (IMiD) derived as an analogue of thalidomide. Manufactured under stringent international validation, it is an advanced clinical tool utilized to disrupt cellular pathways of relapsed and treatment-resistant hematological malignancies. 1. Clinical Indications & Usage Relapsed and Refractory Multiple Myeloma (RRMM): Indicated in combination with dexamethasone for adult patients with multiple myeloma who have received at least two prior therapies—including lenalidomide and a proteasome inhibitor—and have demonstrated disease progression on or within 60 days of completion of the last therapy. Kaposi Sarcoma: Deployed for the treatment of adult patients with AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy (HAART), or in patients who are HIV-negative. 2. Mechanism of Action: How Bdpoma Works Cereblon-E3 Ligase Binding: Pomalidomide binds directly to cereblon (CRBN), an integral component of the cullin-RING E3 ubiquitin ligase enzyme complex. Selective Proteasomal Degradation: This direct structural binding forces the rapid ubiquitination and subsequent degradation of two crucial lymphoid transcription factors: Ikaros (IKZF1) and Aiolos (IKZF3). Immunomodulation: It enhances T-cell and natural killer (NK) cell-mediated immunity, training the patient's immune system to attack surviving cancer cells. 3. Administration and Dosing Guide Administration Route: Oral capsule formulation. It must be swallowed whole with water and never opened, broken, chewed, or crushed due to hazardous exposure risks to raw powder. Food Interactions: Capsules can be taken consistently either with or without food. Standard Schedule: The standard adult dosage for multiple myeloma is 4 mg taken orally once daily on Days 1 through 21 of repeated 28-day cycles, typically in combination with low-dose dexamethasone, until disease progression or unacceptable toxicity. ⚠️ Safety, Side Effects, and Monitoring Embryofetal Toxicity (Boxed Warning): Pomalidomide is a structural analogue of thalidomide and carries a strict warning for severe, life-threatening human birth defects or embryo-fetal death. International compliance with strict pregnancy prevention programs (REMS) is required. Venous Thromboembolism: Patients treated with Bdpoma have an elevated risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE). Antithrombotic prophylaxis is universally recommended. Common Side Effects: Fatigue, weakness, constipation, diarrhea, muscle cramps, dyspnea, upper respiratory tract infections, back pain, and pyrexia. 📦 Storage and Handling Specifications (Anaday & Bdpoma) Storage Framework: Store both products below 30°C (86°F) in dry, dark, climate-controlled, certified pharmaceutical warehouses. Environmental Safeguards: Keep medications sealed inside their original manufacturer protective packaging. Protect completely from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) Verified Batch Origin Ledger &GMP Compliance Global Import/Export Customs Clearance and Compliance Documentation PRESCRIPTION MEDICINE IS: YES Clinical Disclaimer: This profile is compiled strictly for international wholesale procurement, commercial trade evaluation, and institutional research. Anaday 1mg and Bdpoma 4mg are specialized oncology medications available exclusively under valid clinical authorization (PRESCRIPTION MEDICINE IS YES). They must be handled, dispensed, and utilized solely under the direct guidance of registered specialists. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Part 4: Extensive Product Profile: Understanding BDPOMA 2MG CAPSULE Bdpoma 2mg Capsule contains Pomalidomide, an advanced, second-generation immunomodulatory antineoplastic agent (IMiD) derived as an analogue of thalidomide. Manufactured under stringent global pharmaceutical protocols, it is heavily relied upon by hematologists and oncologists worldwide to disrupt cellular pathways of relapsed and treatment-resistant bone marrow malignancies. 1. Clinical Indications & Usage Relapsed and Refractory Multiple Myeloma (RRMM): Indicated in combination with dexamethasone for patients with multiple myeloma who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have demonstrated disease progression on or within 60 days of completion of the last therapy. AIDS-Related Kaposi Sarcoma: Deployed for the treatment of adult patients with AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy (HAART). HIV-Negative Kaposi Sarcoma: Indicated for the treatment of adult patients with Kaposi sarcoma who are HIV-negative. 2. Mechanism of Action: How Bdpoma Works Cereblon-E3 Ligase Targeting: Pomalidomide binds directly to cereblon (CRBN), which is part of the cullin-RING E3 ubiquitin ligase enzyme complex. Selective Proteasomal Degradation: This structural binding selectively induces the ubiquitination and subsequent proteasomal degradation of two crucial lymphoid transcription factors: Ikaros (IKZF1) and Aiolos (IKZF3). Immunomodulation: It enhances T-cell and natural killer (NK) cell-mediated immunity, turning the patient’s own immune system against surviving cancer populations. 3. Administration and Dosing Guide Administration Route: Bdpoma 2mg is an oral capsule formulation. It must be swallowed whole with water and should never be broken, chewed, crushed, split, or opened. Food Interactions: Capsules can be taken consistently either with or without food. ⚠️ Safety, Side Effects, and Monitoring Embryofetal Toxicity (Boxed Warning): Pomalidomide is a thalidomide analogue and poses severe risks of life-threatening human birth defects or embryo-fetal death. Strict risk evaluation and mitigation strategies (REMS) are required internationally. Venous Thromboembolism: Patients treated with Bdpoma have an elevated risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE). Thromboprophylaxis is universally recommended. Common Side Effects: Fatigue, severe neutropenia, anemia, constipation, nausea, diarrhea, dyspnea, upper respiratory tract infections, back pain, and pyrexia. 📦 Storage and Handling Specifications Storage Framework: Store Bdpoma 2mg capsules at controlled room temperature, consistently below 30°C (86°F), in a dry, dark, climate-controlled warehouse corridor. Environmental Safeguards: Keep the capsules sealed tightly inside their original manufacturer protective bottles or blister frames. Protect from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) confirming chemical purity parameters. Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Bdpoma 2mg Capsule is a specialized hematology medication available exclusively under direct clinical authorization (PRESCRIPTION MEDICINE IS YES). It must be handled, dispensed, and utilized solely under the direct guidance of a registered oncology or hematology specialist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding PARALIEVA 500 MG TAB Paralieva 500mg Tablet contains Levetiracetam, an advanced, second-generation broad-spectrum antiepileptic drug (AED) belonging to the pyrrolidine class. Manufactured to strict global pharmaceutical quality metrics, it is prescribed by neurologists worldwide as either monotherapy or adjunctive treatment to control neurological synchronized electrical surges across diverse seizure types. 1. Clinical Indications & Usage Partial-Onset Seizures: Indicated as monotherapy or adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy. Myoclonic Seizures: Deployed as adjunctive therapy for the treatment of myoclonic seizures in adults and adolescents presenting with Juvenile Myoclonic Epilepsy (JME). Primary Generalized Tonic-Clonic Seizures: Indicated as adjunctive therapy for managing primary generalized tonic-clonic seizures in adult and pediatric patients with idiopathic generalized epilepsy. 2. Mechanism of Action: How Paralieva Works SV2A Binding Specificity: Levetiracetam binds selectively and stereospecifically to the Synaptic Vesicle Protein 2A (SV2A), a membrane glycoprotein located on presynaptic vesicles in the brain. Modulation of Neurotransmitter Release: By targeting SV2A, Paralieva modulates synaptic vesicle exocytosis. This effectively controls the hypersynchronized, calcium-dependent release of excitatory neurotransmitters (such as glutamate) into the synaptic cleft. 3. Administration and Dosing Guide Administration Route: Paralieva 500mg is an oral tablet formulation. It must be swallowed whole with fluid and should never be crushed, chewed, split, or dissolved. Food Interactions: Tablets can be taken consistently either with or without food. Standard Schedule: The typical recommended starting adult dosage is 500 mg taken orally twice daily (1,000 mg total daily dose), administered roughly 12 hours apart. Based on clinical response and tolerability, doses may be increased progressively by an experienced neurologist. Renal impairment requires precise dosage adaptations based on creatinine clearance parameters. ⚠️ Safety, Side Effects, and Monitoring Behavioral & Neuropsychiatric Symptoms: Can cause behavioral abnormalities including agitation, hostility, anxiety, irritability, and depression. Patients and caregivers should remain alert for signs of mood alterations or suicidal ideation. Somnolence and Fatigue: Frequently induces somnolence, dizziness, and asthenia, especially during treatment initiation or dose titration phases.Abrupt Withdrawal Risks: Antiepileptic drugs must never be discontinued abruptly. Rapid withdrawal can precipitate status epilepticus or a severe recurrence of breakthrough seizures. Common Side Effects: Nasopharyngitis, headache, dizziness, drowsiness, decreased appetite, and unsteadiness (gait disturbances). 📦 Storage and Handling Specifications Storage Framework: Store Paralieva 500mg tablets at controlled room temperature, consistently below 25°C (77°F), in a dry, dark, climate-controlled warehouse corridor. Environmental Safeguards: Keep the tablets sealed tightly inside their original manufacturer protective blister strips or bottles. Protect from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) confirming chemical purity parameters. Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Paralieva 500mg Tablet is a specialized neurology medication available exclusively under direct clinical authorization (PRESCRIPTION MEDICINE IS YES). It must be handled, dispensed, and utilized solely under the direct guidance of a registered neurologist or specialized healthcare professional. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding Anaday 1mg Tablet Anaday 1mg Tablet contains Anastrozole, a potent and highly selective non-steroidal aromatase inhibitor (Type II aromatase inhibitor). Manufactured to rigorous global pharmaceutical standards, it is prescribed by oncologists worldwide to manage hormone receptor-positive (HR+) breast cancers in postmenopausal women, effectively stopping endocrine-driven tumor progression. 1. Clinical Indications & Usage Adjuvant Treatment of Postmenopausal Early Breast Cancer: Indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. First-Line Treatment of Advanced Breast Cancer: Indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer. Advanced Breast Cancer After Tamoxifen Therapy: Indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. (Patients with ER-negative disease or those who failed to respond to tamoxifen rarely respond to Anastrozole). 2. Mechanism of Action: How Anaday Works Aromatase Enzyme Inhibition: In postmenopausal women, the primary source of circulating estrogen is the conversion of adrenal androgens (androstenedione and testosterone) into estrogens (estrone and estradiol) by the aromatase enzyme complex in peripheral tissues (such as adipose, muscle, and liver tissue) and within tumor cells themselves. Substrate-Competitive Binding: Anastrozole binds reversibly and competitively to the heme group of the aromatase enzyme, completely deactivating its catalytic capacity. 3. Administration and Dosing Guide Administration Route: Anaday 1mg is an oral tablet formulation. It must be swallowed whole with water and should never be chewed, crushed, split, or dissolved. Food Interactions: Tablets can be taken consistently either with or without food. Standard Schedule: The typical recommended adult dosage is 1 mg (one tablet) taken orally once daily. For early-stage breast cancer, the standard duration of adjuvant therapy is typically 5 years, or until disease progression or unacceptable toxicity occurs. Dosing schedules are determined by the treating oncology specialist. ⚠️ Safety, Side Effects, and Monitoring Reduction in Bone Mineral Density (BMD): Because Anastrozole significantly lowers circulating estrogen levels, it can cause decreases in bone mineral density, increasing the risk of osteoporosis and bone fractures. Baseline and periodic bone density monitoring (DEXA scans) are highly recommended. Ischemic Cardiovascular Events: In women with pre-existing ischemic heart disease, an increased incidence of cardiovascular events has been observed compared to tamoxifen. Monitor cardiac symptoms closely. Common Side Effects: Hot flashes, joint pain or stiffness (arthralgia/arthritis), asthenia (weakness/fatigue), skin rash, nausea, headache, back pain, lymphedema, and mild vaginal dryness. 📦 Storage and Handling Specifications Storage Framework: Store Anaday 1mg tablets at controlled room temperature, consistently between 20°C to 25°C (68°F to 77°F), in a dry, dark, climate-controlled warehouse corridor. Environmental Safeguards: Keep the tablets sealed tightly inside their original manufacturer protective blister packaging or bottle. Protect from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) confirming chemical purity parameters. Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Anaday 1mg Tablet is a specialized oncology drug available exclusively under direct clinical authorization (PRESCRIPTION MEDICINE IS YES). It must be handled, dispensed, and utilized solely under the direct guidance of a registered oncology specialist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding Advacan 0.50mg Tablet Advacan 0.50mg Tablet contains Everolimus, an advanced, orally active selective inhibitor of the mammalian target of rapamycin (mTOR) pathway. Manufactured to global pharmaceutical standards, it serves a dual therapeutic purpose: acting as an essential immunosuppressant to prevent transplant rejection and as a targeted antineoplastic therapy to treat advanced, hormone-dependent malignancies. The 0.50mg presentation offers an increased dosage concentration to streamline accurate medication management. 1. Clinical Indications & Usage Prophylaxis of Organ Rejection: Prescribed to prevent immune-mediated organ rejection in adult patients undergoing allogeneic kidney or liver transplantation (typically used in combination with cyclosporine and corticosteroids). Hormone Receptor-Positive Advanced Breast Cancer: Indicated in combination with exemestane for postmenopausal women with advanced HR+, HER2- breast cancer whose disease progressed after non-steroidal aromatase inhibitor therapy. Advanced Neuroendocrine Tumors (NET): Deployed for progressive neuroendocrine tumors of pancreatic origin (pNET), as well as non-functional NETs of gastrointestinal or lung origin that are unresectable, locally advanced, or metastatic. 2. Mechanism of Action: How Advacan Works Selective mTORC1 Pathway Inhibition: Everolimus binds with high affinity to the intracellular receptor protein FKBP12. This complex subsequently interacts with and selectively inhibits the mammalian target of rapamycin complex 1 (mTORC1). Arresting Cell Growth and Angiogenesis: By shutting down mTORC1 signaling, Advacan blocks downstream translation factors (such as p70 S6 kinase and 4E-BP1). This severely restricts protein synthesis critical for cell division, nutrient uptake, and metabolic survival in cancer cells. Furthermore, it downregulates Vascular Endothelial Growth Factor (VEGF) production, lowering tumor-induced angiogenesis (blood vessel formation). 3. Administration and Dosing Guide Strict Consistency Requirements: Tablets can be taken either with or without food, but must be taken consistently with respect to food intake to prevent wild fluctuations in systemic exposure. Avoid concurrent intake of grapefruit or grapefruit juice, as it inhibits CYP3A4 enzymes and dramatically raises drug concentrations to toxic levels. Administration Route: Advacan 0.50mg is an oral tablet formulation. It must be swallowed whole with water and should never be chewed, crushed, split, or dissolved. Standard Schedule: For transplant rejection prophylaxis, typical starting doses range lower (monitored via therapeutic blood level testing). For oncology indications, higher total daily doses are used (e.g., 5mg to 10mg once daily). Dosing configurations must follow exact protocol designs specified by the supervising clinical oncologist or transplant specialist. ⚠️ Safety, Side Effects, and Monitoring Non-Infectious Pneumonitis: Rare but severe cases of lung inflammation (pneumonitis), some fatal, have been reported. Patients presenting with new or worsening respiratory clinical signs (cough, dyspnea) require immediate medical imaging evaluation. Common Side Effects: Mouth sores (stomatitis), nausea, diarrhea, extreme fatigue, skin rash, fever, peripheral edema, headache, and decreased appetite. 📦 Storage and Handling Specifications Storage Framework: Store Advacan 0.50mg tablets at controlled room temperature, consistently below 25°C (77°F), in a dry, dark, climate-controlled corridor. Environmental Safeguards: Keep the tablets tightly sealed inside their original manufacturer protective aluminum strip or blister packaging. Protect from extreme heat, high humidity, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) confirming chemical purity parameters. Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Advacan 0.50mg Tablet is a specialized oncology and transplant drug available exclusively under direct clinical authorization 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding Advacan 0.25mg Tablet Advacan 0.25mg Tablet contains Everolimus, an advanced, orally active selective inhibitor of the mammalian target of rapamycin (mTOR) pathway. Manufactured to global pharmaceutical standards, it serves a dual therapeutic purpose: acting as an essential immunosuppressant to prevent transplant rejection and as a targeted antineoplastic therapy to treat advanced, hormone-dependent malignancies. 1. Clinical Indications & Usage Prophylaxis of Organ Rejection: Prescribed to prevent immune-mediated organ rejection in adult patients undergoing allogeneic kidney or liver transplantation (typically used in combination with cyclosporine and corticosteroids). Hormone Receptor-Positive Advanced Breast Cancer: Indicated in combination with exemestane for postmenopausal women with advanced HR+, HER2- breast cancer whose disease progressed after non-steroidal aromatase inhibitor therapy. Advanced Neuroendocrine Tumors (NET): Deployed for progressive neuroendocrine tumors of pancreatic origin (pNET), as well as non-functional NETs of gastrointestinal or lung origin that are unresectable, locally advanced, or metastatic. 2. Mechanism of Action: How Advacan Works Selective mTORC1 Pathway Inhibition: Everolimus binds with high affinity to the intracellular receptor protein FKBP12. This complex subsequently interacts with and selectively inhibits the mammalian target of rapamycin complex 1 (mTORC1). Arresting Cell Growth and Angiogenesis: By shutting down mTORC1 signaling, Advacan blocks downstream translation factors (such as p70 S6 kinase and 4E-BP1). This severely restricts protein synthesis critical for cell division, nutrient uptake, and metabolic survival in cancer cells. Furthermore, it downregulates Vascular Endothelial Growth Factor (VEGF) production, lowering tumor-induced angiogenesis (blood vessel formation). 3. Administration and Dosing Guide Strict Consistency Requirements: Tablets can be taken either with or without food, but must be taken consistently with respect to food intake to prevent wild fluctuations in systemic exposure. Avoid concurrent intake of grapefruit or grapefruit juice, as it inhibits CYP3A4 enzymes and dramatically raises drug concentrations to toxic levels. Standard Schedule: For transplant rejection prophylaxis, typical starting doses range lower (monitored via therapeutic blood level testing). For oncology indications, higher total daily doses are used (e.g., 5mg to 10mg once daily). Dosing configurations must follow exact protocol designs specified by the supervising clinical oncologist or transplant specialist. ⚠️ Safety, Side Effects, and Monitoring Non-Infectious Pneumonitis: Rare but severe cases of lung inflammation (pneumonitis), some fatal, have been reported. Patients presenting with new or worsening respiratory clinical signs (cough, dyspnea) require immediate medical imaging evaluation. Severe Immunosuppression & Infections: Increased susceptibility to bacterial, fungal, protozoal, or viral opportunistic infections can occur due to decreased immune function. Live vaccines are strictly contraindicated during therapy. Common Side Effects: Mouth sores (stomatitis), nausea, diarrhea, extreme fatigue, skin rash, fever, peripheral edema, headache, and decreased appetite. 📦 Storage and Handling Specifications Storage Framework: Store Advacan 0.25mg tablets at controlled room temperature, consistently below 25°C (77°F), in a dry, dark, climate-controlled corridor. Environmental Safeguards: Keep the tablets tightly sealed inside their original manufacturer protective aluminum strip or blister packaging. Protect from extreme heat, high humidity, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) confirming chemical purity parameters. Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Advacan 0.25mg Tablet is a specialized oncology and transplant drug available exclusively under direct clinical authorization (PRESCRIPTION MEDICINE IS YES). 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding Acalnib 100mg Capsule Acalnib 100mg Capsule contains Acalabrutinib, an advanced, second-generation, highly selective small-molecule Bruton's Tyrosine Kinase (BTK) inhibitor. Manufactured to rigorous international quality benchmarks, it is extensively deployed by global hematologists and oncologists as a highly targeted therapy to manage complex B-cell malignancies. Compared to first-generation BTK inhibitors, its refined molecular structure minimizes off-target binding, dramatically lowering adverse toxicities while maximizing clinical efficacy. 1. Clinical Indications & Usage Chronic Lymphocytic Leukemia (CLL) & Small Lymphocytic Lymphoma (SLL): Indicated as a single agent or in combination regimens for the treatment of adult patients presenting with newly diagnosed or relapsed/refractory CLL or SLL. Mantle Cell Lymphoma (MCL): Prescribed for adult patients with mantle cell lymphoma who have received at least one prior systemic treatment line. 2. Mechanism of Action: How Acalnib Works Selective BTK Inhibition: Acalabrutinib acts as a covalent, small-molecule inhibitor of Bruton's Tyrosine Kinase (BTK). BTK is an integral signaling molecule within the B-cell antigen receptor (BCR) pathway. Disruption of Pro-Survival Pathways: By binding irreversibly to the active site of the BTK protein, Acalnib completely arrests downstream signaling networks, including downstream activation of pathways. Inhibition of Proliferation & Migration: This targeted block starves the malignant B-cells of essential cellular survival and replication signals. Consequently, it stops tumor cell proliferation, halts tissue homing, and disrupts cell adhesion/migration, forcing the malignant cells into programmed cell death (apoptosis) while sparing normal T-cell and NK-cell signaling. 3. Administration and Dosing Guide Administration Route: Acalnib 100mg is an oral capsule formulation. It must be swallowed whole with water and should never be chewed, crushed, opened, or dissolved. Food & Gastric Environment Interactions: Capsules can be taken consistently either with or without food. Crucial Interaction Note: Avoid co-administration with proton pump inhibitors (PPIs) due to pH-dependent solubility limits. If acid-reductive therapy is required, separate dosing from H2-receptor antagonists or local antacids by at least 2 hours. Crucial Interaction Note: Avoid co-administration with proton pump inhibitors (PPIs) due to pH-dependent solubility limits. If acid-reductive therapy is required, separate dosing from H2-receptor antagonists or local antacids by at least 2 hours. ⚠️ Safety, Side Effects, and Monitoring Hemorrhage & Bleeding Risks: Severe and fatal hemorrhagic events can occur. Avoid co-administration with antiplatelet drugs or oral anticoagulants where possible, and temporarily interrupt therapy around surgical procedures. Atrial Fibrillation and Flutter: Periodic cardiac evaluation is required, especially in patients with pre-existing cardiovascular risk factors. Infection Control: Serious bacterial, viral, or fungal infections may develop. Monitor closely for fever, chills, or new respiratory symptoms and treat promptly. Common Side Effects: Headache (frequently resolving after 1-2 weeks), diarrhea, fatigue, muscle pain (myalgia), bruising, and mild rash. 📦 Storage and Handling Specifications Storage Framework: Store Acalnib 100mg capsules consistently between 20°C to 25°C (68°F to 77°F) in a dry, dark, climate-controlled warehouse corridor. Environmental Safeguards: Keep the capsules sealed tightly inside their original manufacturer protective bottle or blister packaging. Protect from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Acalnib 100mg Capsule is a specialized oncology drug available exclusively under direct clinical authorization (PRESCRIPTION MEDICINE IS YES). 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding Abastet 250mg Tablet Abastet 250mg Tablet contains Abiraterone Acetate, an advanced, orally administered systemic steroidal CYP17 inhibitor (anti-androgen/hormonal therapy). Manufactured to rigorous international quality benchmarks, it is extensively deployed by global oncologists in combination with corticosteroids (prednisone or prednisolone) to manage complex, hormone-dependent and mutation-specific malignancies. 1. Clinical Indications & Usage Metastatic Castration-Resistant Prostate Cancer (mCRPC): Indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who have either received prior chemotherapy containing docetaxel or are chemotherapy-naive. Metastatic High-Risk Castration-Sensitive Prostate Cancer (mHSPC): Indicated in combination with prednisone/prednisolone and androgen deprivation therapy (ADT) for patients presenting with newly diagnosed high-risk metastatic hormone-sensitive prostate malignancy. 2. Mechanism of Action: How Abastet Works Selective CYP17 Enzyme Inhibition: Abiraterone acetate is converted in vivo to abiraterone, a potent inhibitor of the CYP17 enzyme complex. This enzyme complex is highly expressed in testicular, adrenal, and prostatic tumor tissues. Tri-Source Androgen Suppression: By blocking CYP17, Abastet halts the conversion of pregnenolone and progesterone into testosterone precursors. This completely disrupts androgen biosynthesis at all three biological sources: the testes, the adrenal glands, and within the tumor microenvironment itself. Slowing Tumor Proliferation: Since prostate cancer cells rely heavily on androgen signaling to multiply, the severe reduction in serum and intratumoral testosterone effectively starves the hormone-dependent malignant cells, forcing them to cease replication and enter programmed cell death (apoptosis). 3. Administration and Dosing Guide Administration Route: Abastet 250mg is an oral tablet formulation. It must be swallowed whole with water and should never be chewed, crushed, dissolved, or split. Strict Food Interactions (Empty Stomach Requirement): Abastet must be taken on an empty stomach. No food should be consumed for at least 2 hours before taking the dose, and no food should be consumed for at least 1 hour after taking the dose. Taking the medication with food significantly increases systemic exposure and can lead to toxicities. ⚠️ Safety, Side Effects, and Monitoring Mineralocorticoid Excess: Due to CYP17 inhibition, compensatory increases in adrenocorticotropic hormone (ACTH) can cause mineralocorticoid excess. This can manifest as severe hypertension, hypokalemia (low potassium), and fluid retention (edema). Blood pressure and potassium levels must be monitored closely at baseline and monthly. Hepatotoxicity: Significant elevations in serum transaminases (ALT and AST) and bilirubin have been reported. Liver Function Tests (LFTs) are mandatory prior to initiating therapy, every 2 weeks for the first 3 months of treatment, and monthly thereafter. Common Side Effects: Joint swelling or pain (arthralgia), muscle discomfort, hot flashes, diarrhea, urinary tract infections, cough, and changes in blood lipid profiles. 📦 Storage and Handling Specifications Storage Framework: Store Abastet 250mg tablets consistently below 20°C to 25°C (68°F to 77°F) in a dry, dark, climate-controlled warehouse corridor. Environmental Safeguards: Keep the tablets sealed tightly inside their original manufacturer protective container. Protect the bottles from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Abastet 250mg Tablet is a specialized oncology drug available exclusively under direct clinical authorization (PRESCRIPTION MEDICINE IS YES). It must be handled, dispensed, and utilized solely under the direct guidance of a registered oncology specialist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding Abiralieva 500mg Tablet Abiralieva 500mg Tablet contains Abiraterone Acetate, an advanced, orally administered systemic steroidal CYP17 inhibitor (anti-androgen/hormonal therapy). Manufactured to rigorous international quality benchmarks, it is extensively deployed by global oncologists in combination with corticosteroids (prednisone or prednisolone) to manage complex, hormone-dependent and mutation-specific malignancies. 1. Clinical Indications & Usage Metastatic Castration-Resistant Prostate Cancer (mCRPC): Indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who have either received prior chemotherapy containing docetaxel or are chemotherapy-naive. Metastatic High-Risk Castration-Sensitive Prostate Cancer (mHSPC): Indicated in combination with prednisone/prednisolone and androgen deprivation therapy (ADT) for patients presenting with newly diagnosed high-risk metastatic hormone-sensitive prostate malignancy. 2. Mechanism of Action: How Abiralieva Works Selective CYP17 Enzyme Inhibition: Abiraterone acetate is converted in vivo to abiraterone, a potent inhibitor of the CYP17 enzyme complex . This enzyme complex is highly expressed in testicular, adrenal, and prostatic tumor tissues. Tri-Source Androgen Suppression: By blocking CYP17, Abiralieva halts the conversion of pregnenolone and progesterone into testosterone precursors. This completely disrupts androgen biosynthesis at all three biological sources: the testes, the adrenal glands, and within the tumor microenvironment itself. Slowing Tumor Proliferation: Since prostate cancer cells rely heavily on androgen signaling to multiply, the severe reduction in serum and intratumoral testosterone effectively starves the hormone-dependent malignant cells, forcing them to cease replication and enter programmed cell death (apoptosis). 3. Administration and Dosing Guide Administration Route: Abiralieva 500mg is an oral tablet formulation. It must be swallowed whole with water and should never be chewed, crushed, dissolved, or split. Strict Food Interactions (Empty Stomach Requirement): Abiralieva must be taken on an empty stomach. No food should be consumed for at least 2 hours before taking the dose, and no food should be consumed for at least 1 hour after taking the dose. Taking the medication with food significantly increases systemic exposure and can lead to severe toxicities. ⚠️ Safety, Side Effects, and Monitoring Mineralocorticoid Excess: Due to CYP17 inhibition, compensatory increases in adrenocorticotropic hormone (ACTH) can cause mineralocorticoid excess. This can manifest as severe hypertension, hypokalemia (low potassium), and fluid retention (edema). Blood pressure and potassium levels must be monitored closely at baseline and monthly. Adrenocortical Insufficiency: May occur if patients are under physical stress or if their concurrent corticosteroid dose is stopped abruptly. Common Side Effects: Joint swelling or pain (arthralgia), muscle discomfort, hot flashes, diarrhea, urinary tract infections, cough, and changes in blood lipid profiles. 📦 Storage and Handling Specifications Storage Framework: Store Abiralieva 500mg tablets consistently below 20°C to 25°C (68°F to 77°F) in a dry, dark, climate-controlled warehouse corridor. Environmental Safeguards: Keep the tablets sealed tightly inside their original manufacturer protective container. Protect the bottles from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) Verified Batch Origin Ledger and commercial export documentation. GMP compliant manufacturing credentials. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📋 PRESCRIPTION MEDICINE: YES Clinical Disclaimer: This comprehensive profile is compiled strictly for international wholesale procurement, commercial trade research, and institutional sourcing evaluation. Abiralieva 500mg Tablet is a specialized oncology drug available exclusively under direct clinical authorization (PRESCRIPTION MEDICINE IS YES). It must be handled, dispensed, and utilized solely under the direct guidance of a registered oncology specialist. 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

📑 Extensive Product Profile: Understanding Abiralieva 250mg Tablet 1. Clinical Indications & Usage Metastatic Castration-Resistant Prostate Cancer (mCRPC): Indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who have either received prior chemotherapy containing docetaxel or are chemotherapy-naive. Metastatic High-Risk Castration-Sensitive Prostate Cancer (mHSPC): Indicated in combination with prednisone/prednisolone and androgen deprivation therapy (ADT) for patients presenting with newly diagnosed high-risk metastatic hormone-sensitive prostate malignancy. Selective CYP17 Enzyme Inhibition: Abiraterone acetate is converted in vivo to abiraterone, a potent inhibitor of the CYP17 enzyme complex (17α-hydroxylase/C17,20-lyase). This enzyme complex is highly expressed in testicular, adrenal, and prostatic tumor tissues. Tri-Source Androgen Suppression: By blocking CYP17, Abiralieva halts the conversion of pregnenolone and progesterone into testosterone precursors. This completely disrupts androgen biosynthesis at all three biological sources: the testes, the adrenal glands, and within the tumor microenvironment itself. 3. Administration and Dosing Guide Administration Route: Abiralieva 250mg is an oral tablet formulation. It must be swallowed whole with water and should never be chewed, crushed, dissolved, or split. Strict Food Interactions (Empty Stomach Requirement): Abiralieva must be taken on an empty stomach. No food should be consumed for at least 2 hours before taking the dose, and no food should be consumed for at least 1 hour after taking the dose. Taking the medication with food significantly increases systemic exposure and can lead to toxicities. Standard Schedule: The typical recommended adult dosage is 1,000 mg (four 250 mg tablets) taken orally once daily, always in combination with a low-dose corticosteroid (such as Prednisone 5 mg twice daily or as instructed by the specialist). Dose titrations or temporary interruptions may be managed by the treating oncologist based on hepatic tolerance and toxicities. ⚠️ Safety, Side Effects, and Monitoring Mineralocorticoid Excess: Due to CYP17 inhibition, compensatory increases in adrenocorticotropic hormone (ACTH) can cause mineralocorticoid excess. This can manifest as severe hypertension, hypokalemia (low potassium), and fluid retention (edema). Blood pressure and potassium levels must be monitored closely at baseline and monthly. Hepatotoxicity: Significant elevations in serum transaminases (ALT and AST) and bilirubin have been reported. Liver Function Tests (LFTs) are mandatory prior to initiating therapy, every 2 weeks for the first 3 months of treatment, and monthly thereafter. Common Side Effects: Joint swelling or pain (arthralgia), muscle discomfort, hot flashes, diarrhea, urinary tract infections, cough, and changes in blood lipid profiles. 📦 Storage and Handling Specifications Storage Framework: Store Abiralieva 250mg tablets consistently below 20°C to 25°C (68°F to 77°F) in a dry, dark, climate-controlled warehouse corridor. Environmental Safeguards: Keep the tablets sealed tightly inside their original manufacturer protective container. Protect the bottles from high humidity, excess moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic pets. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA) GMP compliant manufacturing credentials. Verified Batch Origin Ledger and commercial export documentation. 💡 Why Choose PRIMECARE IMPEX? Full Traceability Regulatory Alignment Secure Bulk Supply 📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India [GROUP OF PRIME CARE IMPEX PVT. LTD.] Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Primecare Impex is a trusted exporter of Abiraterone acetate tablet 250 mg for global pharmaceutical supply. High-quality oncology tablets available for bulk orders, distributors, hospitals, and importers. /abiraterone-acetate-tablet-250-mg-exporter Abiraterone acetate tablet 250 mg anty cancar oncology tablets exporter pharmaceutical exporter from India bulk cancer medicine supplier Abiraterone tablets wholesale Abiraterone Acetate Tablet 250 mg Trusted Global Supplier of High-Quality Oncology Tablets Primecare Impex is a reliable pharmaceutical exporter specializing in Abiraterone acetate tablet 250 mg for international distributors, hospital procurement companies, wholesalers, and bulk buyers. We supply quality-assured oncology medicines with export-focused packaging, regulatory support, and dependable bulk fulfillment capabilities. Request Bulk Pricing & Export Support Bulk order assistance International shipping support Fast response for distributor inquiries Export documentation support WhatsApp Us: +91 9673008130 Website: www.medicineexporterfromindia.com Abiraterone acetate tablet 250 mg is an oncology medication commonly used in the treatment of prostate cancer. It works by reducing androgen production in the body, helping slow the growth and progression of cancer cells. Primecare Impex supplies pharmaceutical-grade Abiraterone tablets manufactured under strict quality standards to support global pharmaceutical distribution and institutional procurement requirements. Product Name: Zybiraa 250mg Tablet Generic Name: Abiraterone Acetate Composition: Abiraterone acetate tablet 250 mg Strength: 250 mg Dosage Form: Tablet Packaging: 1*120 Tablets Shelf Life: 24 Months Category: Oncology Medicine Supply Type: Bulk Supply & Export Intended Market: Global Pharmaceutical Distribution Each tablet contains: Abiraterone Acetate 250 mg Manufactured using pharmaceutical-grade raw materials under controlled quality standards. Dosage Form Oral Tablet Strength 250 mg Packaging Available in export-standard packaging: 1 x 120 Tablets Customized bulk packaging options may be available for institutional and distributor requirements. Shelf Life 24 Months Store in a cool, dry place away from direct sunlight and moisture. Abiraterone acetate tablet 250 mg is primarily indicated for: Prostate cancer treatment support Advanced prostate cancer management Hormone-related oncology therapy Oncology treatment protocols prescribed by healthcare professionals Abiraterone acetate works by inhibiting CYP17, an enzyme involved in androgen production. By lowering androgen levels, the medicine helps reduce the stimulation and growth of prostate cancer cells. Why Choose Primecare Impex Reliable Pharmaceutical Export Partner Primecare Impex is committed to delivering dependable pharmaceutical export solutions for global buyers. Our Strengths Trusted pharmaceutical exporter from India Focus on oncology medicine supply Bulk supply capabilities for distributors and hospitals Export-ready packaging and documentation support Consistent quality standards Responsive customer support team Timely order processing and shipment coordination We prioritize long-term partnerships built on quality, reliability, and transparent communication. Global Export Capability Primecare Impex supports international pharmaceutical supply requirements for importers, wholesalers, hospital procurement teams, and distributors across regulated and semi-regulated markets. Export Support Includes: Bulk order management Commercial export documentation Secure pharmaceutical packaging Logistics coordination Reliable international supply chain support For large-volume inquiries, our team provides dedicated assistance throughout the procurement process. Looking for a Trusted Supplier of Abiraterone Acetate Tablet 250 mg? Partner with Primecare Impex for dependable oncology medicine exports and bulk pharmaceutical supply. Contact Our Export Team Today Website: www.medicineexporterfromindia.com WhatsApp: +91 9673008130 Request: Bulk pricing Distributor partnership opportunities Export documentation details Product availability International shipping support To be administered strictly under medical supervision Dosage depends on patient condition and physician recommendations Typically used as part of a prescribed oncology treatment regimen Tablets should be taken as directed by healthcare professionals Do not self-medicate or alter dosage without medical advice. Oncology Medicines Exporter Pharmaceutical Exporter from India Cancer Medicine Bulk Supplier Generic Oncology Tablets Hospital Supply Pharmaceutical Products International Pharmaceutical Distribution Services